Ads
related to: new asthma and copd treatments
Search results
AMGEN HIGHLIGHTS NEW COPD, ASTHMA AND VASCULITIS RESEARCH AT ATS 2024
KAMR Amarillo· 3 days agoAmgen (NASDAQ:AMGN) today announced the presentation of new respiratory data at the American Thoracic Society (ATS) 2024 International...San Diego. "We look forward to presenting ...
FTC Moves to Allow Generic Versions of Ozempic
Futurism via Yahoo Finance· 14 hours agoThe Federal Trade Commission is seeking to clear the path for generic Ozempic — but there will be a long road ahead before cheaper versions of the...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 2 days agoPDUFA Target Action Date of June 26, 2024 Eight posters including two oral presentations support potential of ensifentrine,an investigational, first-in-class, selective, dual inhibitor of PDE3 and PDE4 LONDON and RALEIGH, N.C., May 02, 2024
The FTC Strikes Again – Challenging the Listing of 300+ Patents in FDA’s Orange Book | JD Supra
JD Supra· 20 hours agoOn April 30, 2024, the FTC issued a press release[1] and warning letters to ten pharmaceutical companies notifying them that the FTC had “availed [themselves] of the FDA’s regulatory process ...
MannKind advances new inhaled NTM lung disease treatment By Investing.com
Investing.com· 5 days agoMannKind (NASDAQ:MNKD) Corporation (NASDAQ:MNKD), a biopharmaceutical company, announced today the...
Plant-based diet may reduce risk of emphysema among smokers
United Press International via Yahoo News· 4 days agoFor the study, researchers...whether they'd developed emphysema, among other health problems....
Foresee Pharmaceuticals Announces First Subject Dosed in its First-in-Human Clinical Trial of FP-020
WTNH-TV New Haven· 4 days agoForesee Pharmaceuticals (TPEx: 6576), ("Foresee") today announced that the first subject has been...
Amgen (AMGN) Q1 Earnings Top, Stock Up on Obesity Drug Update
Zacks via Yahoo Finance· 11 hours agoAmgen (AMGN) beats first-quarter 2024 estimates for earnings and sales. Amgen is "very encouraged"...
Novo’s Blockbuster Ozempic Among FTC’s Latest Patent Targets
Bloomberg Law· 3 days agoOzempic and Victoza are among 20 branded drugs the Federal Trade Commission is targeting as it challenges more than 300 “junk patent listings” in the FDA’s registry of approved drugs in an effort ...
MannKind Announces IND Clearance From U.S. FDA to Start Phase 3 Study of Clofazimine Inhalation...
Benzinga· 5 days agoFood and Drug Administration (FDA) has cleared the company's Investigational New Drug (IND) application for MNKD-101 (Clofazimine Inhalation Suspension), enabling the initiation ...
